MarketInOut Stock Screener Log In | Sign Up

genOway S.A.

PAR • Healthcare • Biotechnology • Quote as of 10/30/2026
genOway S.A. stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization26.9 mln
Float8.39 mln

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-2.19
Caution advised

Relative Strength

22 / 100
Significantly lagging

Debt / Equity

0.70
Moderate leverage

Pre-Tax Margin

-30%
Deeply loss-making

ROE

-9.86
Negative

Business Description

Founded in 1999 and headquartered in Lyon, France, genOway develops and sells specialized animal and cell models used in medical and scientific research. The company creates custom genetically engineered mice, rats, and cell lines for pharmaceutical firms, life science companies, and academic institutions around the world. It also offers a range of ready-to-use models designed to support drug discovery and the study of the human immune system.

Key Fundamentals

EPS-0.15
ROE-9.86
RPS1.60
ROIC-6.31
ROA-4.87
Interest Cover-16.78
EBITDA, mln-1.91
EV / EBITDA-21.39
EV / EBIT-7.48
Revenue, mln19.77
EV / Revenue2.06

Quote Details

Last 2.07
Change 0 (0%)
Open 2.12
Volume 6,773
Turnover 14,020
Average Volume 8,700.67

Financial Ratios

Pre-Tax Profit Margin-30
Leverage Ratio2.09
Current Ratio2.29
Price / Book1.32
Price / Tangible Book2.05
Debt / Equity0.70
Price / Sales1.45

Financial Strength

Altman Z-Score1.64
Piotroski F-Score 2 / 9
Beneish M-Score-2.19
Price to Intrinsic Value19.50
Shiller PE Ratio29.32

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.91% 7 / 100   
1 Month -8% 19 / 100   
2 Months -15.85% 17 / 100   
6 Months -14.81% 24 / 100   
1 Year -23.05% 21 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog